Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating remdesivir plus tocilizumab versus remdesivir plus placebo in hospitalized patients with severe COVID-19 pneumonia; results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Remdesivir (remdesivir)
• Tocilizumab (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: COVID-19 Pneumonia | Phase 3 | Status: COMPLETED | Results posted: 2022-02-14